NEW YORK – African genomics research company 54gene said on Tuesday that it has closed a $15 million Series A financing round.
The round was led by Adjuvant Capital, a life sciences fund backed by the International Finance Corporation, Novartis, and the Bill & Melinda Gates Foundation. Raba Capital, V8 Capital, and Ingressive Capital also participated in the round, while Y Combinator, Better Ventures, Fifty Years, KdT Ventures, Aera VC, and Pioneer Fund provided follow-on investment.